CS210684B2 - Manufacturing process of 2-aminopyrimidones - Google Patents

Manufacturing process of 2-aminopyrimidones Download PDF

Info

Publication number
CS210684B2
CS210684B2 CS792440A CS244079A CS210684B2 CS 210684 B2 CS210684 B2 CS 210684B2 CS 792440 A CS792440 A CS 792440A CS 244079 A CS244079 A CS 244079A CS 210684 B2 CS210684 B2 CS 210684B2
Authority
CS
Czechoslovakia
Prior art keywords
methyl
pyrimidone
pyridyl
formula
methoxy
Prior art date
Application number
CS792440A
Other languages
Czech (cs)
English (en)
Inventor
Thomas H Brown
Original Assignee
Smith Kline French Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smith Kline French Lab filed Critical Smith Kline French Lab
Priority to CS804466A priority Critical patent/CS210685B2/cs
Publication of CS210684B2 publication Critical patent/CS210684B2/cs

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/47—One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Nutrition Science (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
CS792440A 1978-04-11 1979-04-10 Manufacturing process of 2-aminopyrimidones CS210684B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CS804466A CS210685B2 (cs) 1979-04-10 1980-06-24 Způsob výroby 2-nitroaminopyrimidonů

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB1404978 1978-04-11

Publications (1)

Publication Number Publication Date
CS210684B2 true CS210684B2 (en) 1982-01-29

Family

ID=10034068

Family Applications (1)

Application Number Title Priority Date Filing Date
CS792440A CS210684B2 (en) 1978-04-11 1979-04-10 Manufacturing process of 2-aminopyrimidones

Country Status (31)

Country Link
US (1) US4523015A (no)
EP (1) EP0004793B1 (no)
JP (1) JPS54138580A (no)
KR (1) KR820002136B1 (no)
AT (1) AT372956B (no)
AU (1) AU527202B2 (no)
CA (1) CA1138453A (no)
CS (1) CS210684B2 (no)
CY (1) CY1194A (no)
DD (1) DD142878A5 (no)
DE (1) DE2961652D1 (no)
DK (1) DK147379A (no)
ES (1) ES479469A1 (no)
FI (1) FI791143A (no)
GR (1) GR66986B (no)
HU (1) HU180081B (no)
IE (1) IE48080B1 (no)
IL (1) IL57005A (no)
IT (1) IT1118476B (no)
KE (1) KE3284A (no)
MX (1) MX5898E (no)
MY (1) MY8500703A (no)
NO (1) NO791225L (no)
NZ (1) NZ190122A (no)
PH (2) PH16240A (no)
PL (2) PL118404B1 (no)
PT (1) PT69464A (no)
RO (1) RO76810A (no)
SU (2) SU944504A3 (no)
YU (1) YU84179A (no)
ZA (1) ZA791616B (no)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IN151188B (no) * 1978-02-13 1983-03-05 Smith Kline French Lab
CA1140129A (en) * 1979-08-21 1983-01-25 Ronald J. King 4-pyrimidone derivatives
CA1155842A (en) * 1980-03-29 1983-10-25 Thomas H. Brown Compounds
US4352933A (en) * 1981-02-06 1982-10-05 Smithkline Beckman Corporation Chemical methods and intermediates for preparing substituted pyrimidinones
ZA823149B (en) * 1981-05-27 1983-03-30 Smithkline Beckman Corp Chemical process
PT74865B (en) * 1981-05-27 1983-12-07 Smithkline Beckman Corp Process of preparing a 2-(pyridylbutylamino)-pyrimidone and of its pharmaceutically acceptable salts
DK230482A (da) * 1981-05-30 1982-12-01 Smith Kline French Lab Pyrimidonsalt og fremstilling heraf
US4772704A (en) * 1983-09-21 1988-09-20 Bristol-Myers Company 2,5-disubstituted-4(3H)-pyrimidones having histamine H2 -receptor antagonist activity
IL75400A (en) * 1984-06-16 1988-10-31 Byk Gulden Lomberg Chem Fab Dialkoxypyridine methyl(sulfinyl or sulfonyl)benzimidazoles,processes for the preparation thereof and pharmaceutical compositions containing the same
GB8421427D0 (en) * 1984-08-23 1984-09-26 Smith Kline French Lab Chemical compounds
DE3532880A1 (de) * 1985-09-14 1987-03-26 Basf Ag 1,4-disubstituierte pyrazolderivate
JP2807577B2 (ja) * 1990-06-15 1998-10-08 エーザイ株式会社 環状アミド誘導体
CN107698501A (zh) * 2017-10-25 2018-02-16 遵义医学院 5,6‑二甲基‑2‑羟基烟酸的制备工艺
WO2022034121A1 (en) 2020-08-11 2022-02-17 Université De Strasbourg H2 blockers targeting liver macrophages for the prevention and treatment of liver disease and cancer

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE787372A (fr) * 1971-08-09 1973-02-09 Ici Ltd 2-nitroamino-6-hydroxy-4-methylpyrimidines substituees en position 5
GB1383676A (en) * 1972-07-14 1974-02-12 Ici Ltd Process for making diethylamino pyrimidine derivatives
GB1419994A (en) * 1973-05-03 1976-01-07 Smith Kline French Lab Heterocyclicalkylaminotheterocyclic compounds methods for their preparation and compositions comprising them
IN146736B (no) * 1975-10-02 1979-08-25 Smith Kline French Lab
US4145546A (en) * 1975-10-02 1979-03-20 Smith Kline & French Laboratories Limited 4-Pyrimidone compounds
MW5076A1 (en) * 1975-12-29 1978-02-08 Smith Kline French Lab Pharmacologicalle active compounds
US4216318A (en) * 1975-12-29 1980-08-05 Smith Kline & French Laboratories Limited Heterocyclic alkyl 4-pyrimidones
US4154834A (en) * 1975-12-29 1979-05-15 Smith Kline & French Laboratories Limited Substituted isocytosines having histamine H2 -antagonist activity
US4227000A (en) * 1978-04-11 1980-10-07 Smith Kline & French Laboratories Limited Intermediates in the process for making histamine antagonists
ZA793392B (en) * 1978-07-15 1980-08-27 Smith Kline French Lab Isoureas and isothioureas

Also Published As

Publication number Publication date
PL214792A1 (no) 1980-03-24
DK147379A (da) 1979-10-12
YU84179A (en) 1983-04-30
EP0004793B1 (en) 1981-12-30
NZ190122A (en) 1982-03-09
PT69464A (en) 1979-05-01
EP0004793A3 (en) 1979-11-28
DE2961652D1 (en) 1982-02-18
ZA791616B (en) 1980-04-30
AT372956B (de) 1983-12-12
AU527202B2 (en) 1983-02-24
IT7967751A0 (it) 1979-04-09
ATA267079A (de) 1983-04-15
DD142878A5 (de) 1980-07-16
FI791143A (fi) 1979-10-12
PH16841A (en) 1984-03-15
NO791225L (no) 1979-10-12
US4523015A (en) 1985-06-11
IL57005A (en) 1983-11-30
IE48080B1 (en) 1984-09-19
IE790364L (en) 1979-10-11
MY8500703A (en) 1985-12-31
GR66986B (no) 1981-05-15
SU906376A3 (ru) 1982-02-15
MX5898E (es) 1984-08-22
ES479469A1 (es) 1979-07-16
JPS54138580A (en) 1979-10-27
KR820002136B1 (ko) 1982-11-15
IT1118476B (it) 1986-03-03
PH16240A (en) 1983-08-11
EP0004793A2 (en) 1979-10-17
RO76810A (ro) 1981-05-30
CY1194A (en) 1983-12-31
PL118404B1 (en) 1981-10-31
KE3284A (en) 1983-05-13
PL117998B1 (en) 1981-09-30
AU4571479A (en) 1979-10-18
CA1138453A (en) 1982-12-28
HU180081B (en) 1983-01-28
SU944504A3 (ru) 1982-07-15

Similar Documents

Publication Publication Date Title
CS210684B2 (en) Manufacturing process of 2-aminopyrimidones
JP2002537298A (ja) ピリジン化合物およびその医薬用途
CS203995B2 (en) Method of producing heterocyclic compounds
AU702609B2 (en) Pyridylthio compounds for controlling helicobacter bacteria
AU2002247726B2 (en) 2-thio-substituted imidazole derivatives and the use thereof in the pharmaceutical industry
US4227000A (en) Intermediates in the process for making histamine antagonists
HRP20050239A2 (en) 2 thio-substituted imidazole derivates and their use in pharmacy
Brown et al. Isocytosine H2-receptor histamine antagonists II. Synthesis and evaluation of biological activity at histamine H1-and H2-receptors of 5-(heterocyclyl) methylisocytosines
US4569996A (en) Process for preparing substituted pyrimidinones
JPS58118585A (ja) 抗潰瘍薬
NZ538222A (en) 2-Thio-substituted imidazole derivatives and their use in pharmaceuticals